home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

How to Optimize Patient and Clinician Outcome Assessment Data (COA) in Early Phase Clinical Trials

 
  October 25, 2022  
     
 
Xtalks, online
2022 -10-28


In this webinar, a team of expert panelists will answer key questions around the importance of clinical outcome assessment (COA) data in early phase trials. They’ll take a deep dive into frequently asked questions around effective COA collection strategies including the debate between paper vs. electronic diaries, electronic COA (eCOA) collection in decentralized and hybrid trials, regulatory requirements and guidance on patient-reported data, benefits of real-time data access and more!
 
Join the speakers as they explore issues which impact data quality and patient burden for biotechs, pharma and CROs.
 
 
Organized by: Xtalks
Invited Speakers: Donna L. Reed, Consultant to the pharma industry Bryan McDowell, MSc, MBA, Vice President, eCOA Clinical Science & Consulting Kelly Dumais, PhD, Principal Scientific Advisor (Moderator) Chris Vogel, Executive Director, eCOA Solutions, Clario
 
Deadline for Abstracts: 2022 -10-28
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.